An observational study of haemophilia A patients without inhibitors using the French national claims (SNDS) database | Synapse

⌘+K

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Patient Preferences for the Treatment of Haemophilia A and B in FranceSystematic Review · 2026
2Treatment of Haemophilia A Without Inhibitors: Real‐World Treatment Patterns and Clinical Outcomes in the USHuman Clinical Trial · 2026 · 3 citations
3Outcome of acquired haemophilia in France: the prospective SACHA (Surveillance des Auto antiCorps au cours de l'Hémophilie Acquise) registryRegistry Study · 2013 · 159 citations
4Describing the clinical outcomes and treatment landscape for male haemophilia A and B patients in a real-world setting across Europe and the United StatesCross-Sectional Study · 2026
5Assessment of joint health in patients receiving prophylaxis for haemophilia A: a cross-sectional survey in five European countries2024 · 5 citations
6Patient‐reported outcomes of 182 adults with severe haemophilia in Germany comparing prophylactic vs. on‐demand replacement therapyCohort Study · 2013 · 19 citations
7Real‐World Unmet Needs of Patients With Haemophilia A and Haemophilia B With or Without Inhibitors: End‐of‐Study Results From the explorer6 Non‐Interventional StudyCohort Study · 2025 · 3 citations
8Challenges and Opportunities in Post‐Marketing Reporting of Factor VIII Inhibitors With Efanesoctocog AlfaMeta-Analysis · 2026 · 3 citations
9Icaritin enhances the anti-leukemic activity of imatinib in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia cells: functional involvement of PI3K/AKT signalingHematology · 2026
10Hetrombopag in China: expanding indications, comparative positioning, and risk management - a critical narrative reviewHematology · 2026

More from Hematology

More from Inserm